title: Linear IgA bullous dermatosis following influenza vaccination.
abstract: Linear IgA Bullous Dermatosis (LABD) is an immune-mediated subepidermal vesiculobullous eruption characterized by linear deposits of IgA at the basement membrane zone. Most cases are idiopathic but medications, infections, and malignancies have also been reported to induce LABD. We report the case of a 54-year-old woman who developed LABD shortly after receiving an influenza vaccination.
authors: Division of Dermatology, Department of Medicine, UMass Memorial Healthcare, Worcester, Massachusetts, USA.
authors: Lauren
authors: L
authors: Alberta-Wszolek
authors: Alyse M
authors: AM
authors: Mousette
authors: Meera
authors: M
authors: Mahalingam
authors: Nikki A
authors: NA
authors: Levin
mesh_terms: D003875:Drug Eruptions / Q000209:etiology* / Q000276:immunology; D005260:Female; D005500:Follow-Up Studies; D006229:Hand Dermatoses / Q000139:chemically induced / Q000473:pathology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis / Q000276:immunology*; D007150:Immunohistochemistry; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control; D007868:Leg Dermatoses / Q000139:chemically induced / Q000473:pathology; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012720:Severity of Illness Index; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D016896:Treatment Outcome; D014611:Vaccination / Q000009:adverse effects
chemical_list: D007070:Immunoglobulin A; D007252:Influenza Vaccines; D011241:Prednisone